You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 161 No. 20, November 12, 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Special Article
 This Article
 •Full text
 •PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (14)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Genetic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?


Accuracy and Ambiguity in Counseling Patients About Genetic Risk

Farrell J. Lloyd, MD, MPH; Valerie F. Reyna, PhD; Patrick Whalen, BA

Arch Intern Med. 2001;161:2411-2413.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

A patient from Phoenix, Ariz, recently diagnosed as having diabetes mellitus has a deep tan. He read about hemochromatosis on a Web site and is concerned that he might have the condition. His mother died of congestive heart failure and his paternal uncle had diabetes mellitus and severe arthritis. He wants to obtain testing for an HFE gene mutation. He asks, "If I have the gene, could that be the reason for my diabetes mellitus? What should I do if I am tested and I have the gene? If I do not have the gene, could I still have the disease? Should my children be tested?"

Recent research has greatly increased knowledge of gene mutations that are responsible for a wide array of diseases. As basic science increases the understanding of these mutations, clinicians are asking if there . . . [Full Text of this Article]

PHYSICIANS AND GENETIC COUNSELING

GENETICS AND HEMOCHROMATOSIS

VISUAL REPRESENTATIONS OF POSTTEST PREDICTIVE VALUES

SUMMARY

From the Department of Internal Medicine (Dr Lloyd), Mayo Clinic Scottsdale, Scottsdale, and the Departments of Surgery (Dr Reyna and Mr Whalen) and Internal Medicine (Dr Reyna), University of Arizona, Tucson.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Genetic Testing and Medical Decision Making
Valerie F. Reyna, Farrell J. Lloyd, and Patrick Whalen
Arch Intern Med. 2001;161(20):2406-2408.
EXTRACT | FULL TEXT  

Association of Mutations in the Hemochromatosis Gene With Shorter Life Expectancy
Lise Bathum, Lene Christiansen, Hanne Nybo, Karen Andersen Ranberg, David Gaist, Bernard Jeune, Niels Erik Petersen, James Vaupel, and Kaare Christensen
Arch Intern Med. 2001;161(20):2441-2444.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Theory of Medical Decision Making and Health: Fuzzy Trace Theory
Reyna
Med Decis Making 2008;28:850-865.
ABSTRACT  

Women's Interest in Gene Expression Analysis for Breast Cancer Recurrence Risk
O'Neill et al.
JCO 2007;25:4628-4634.
ABSTRACT | FULL TEXT  

Community Involvement in Developing Policies for Genetic Testing: Assessing the Interests and Experiences of Individuals Affected by Genetic Conditions
Gollust et al.
AJPH 2005;95:35-41.
ABSTRACT | FULL TEXT  

Limitations of Direct-to-Consumer Advertising for Clinical Genetic Testing
Gollust et al.
JAMA 2002;288:1762-1767.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.